These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23649458)

  • 1. The effect of immune therapy on surgical site infection following Crohn's Disease resection.
    Serradori T; Germain A; Scherrer ML; Ayav C; Perez M; Romain B; Palot JP; Rohr S; Peyrin-Biroulet L; Bresler L
    Br J Surg; 2013 Jul; 100(8):1089-93. PubMed ID: 23649458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn's disease patients.
    Syed A; Cross RK; Flasar MH
    Am J Gastroenterol; 2013 Apr; 108(4):583-93. PubMed ID: 23481144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications in surgery for Crohn's disease after preoperative antitumour necrosis factor therapy.
    Myrelid P; Marti-Gallostra M; Ashraf S; Sunde ML; Tholin M; Oresland T; Lovegrove RE; Tøttrup A; Kjaer DW; George BD
    Br J Surg; 2014 Apr; 101(5):539-45. PubMed ID: 24615529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive histological inflammatory margins are associated with increased risk for intra-abdominal septic complications in patients undergoing ileocolic resection for Crohn's disease.
    Shental O; Tulchinsky H; Greenberg R; Klausner JM; Avital S
    Dis Colon Rectum; 2012 Nov; 55(11):1125-30. PubMed ID: 23044672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for postoperative intra-abdominal septic complications after bowel resection in patients with Crohn's disease.
    Kanazawa A; Yamana T; Okamoto K; Sahara R
    Dis Colon Rectum; 2012 Sep; 55(9):957-62. PubMed ID: 22874602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
    Colombel JF; Loftus EV; Tremaine WJ; Pemberton JH; Wolff BG; Young-Fadok T; Harmsen WS; Schleck CD; Sandborn WJ
    Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical resection in Crohn's disease: is immunosuppressive medication associated with higher postoperative infection rates?
    Canedo J; Lee SH; Pinto R; Murad-Regadas S; Rosen L; Wexner SD
    Colorectal Dis; 2011 Nov; 13(11):1294-8. PubMed ID: 20969715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with Crohn's disease--a nationwide cohort study.
    Nørgård BM; Nielsen J; Qvist N; Gradel KO; de Muckadell OB; Kjeldsen J
    Aliment Pharmacol Ther; 2013 Jan; 37(2):214-24. PubMed ID: 23190161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining Predictors for Intra-abdominal Septic Complications Following Ileocolonic Resection for Crohn's Disease-Considerations in Pre-operative and Peri-operative Optimisation Techniques to Improve Outcome.
    Morar PS; Hodgkinson JD; Thalayasingam S; Koysombat K; Purcell M; Hart AL; Warusavitarne J; Faiz O
    J Crohns Colitis; 2015 Jun; 9(6):483-91. PubMed ID: 25796553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiopurine therapy is associated with postoperative intra-abdominal septic complications in abdominal surgery for Crohn's disease.
    Myrelid P; Olaison G; Sjödahl R; Nyström PO; Almer S; Andersson P
    Dis Colon Rectum; 2009 Aug; 52(8):1387-94. PubMed ID: 19617749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for surgical site infection and association with infliximab administration during surgery for Crohn's disease.
    Uchino M; Ikeuchi H; Matsuoka H; Bando T; Ichiki K; Nakajima K; Tomita N; Takesue Y
    Dis Colon Rectum; 2013 Oct; 56(10):1156-65. PubMed ID: 24022533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn's disease: a multivariate analysis in 161 consecutive patients.
    Alves A; Panis Y; Bouhnik Y; Pocard M; Vicaut E; Valleur P
    Dis Colon Rectum; 2007 Mar; 50(3):331-6. PubMed ID: 17252288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn's disease.
    El-Hussuna A; Andersen J; Bisgaard T; Jess P; Henriksen M; Oehlenschlager J; Thorlacius-Ussing O; Olaison G
    Scand J Gastroenterol; 2012 Jun; 47(6):662-8. PubMed ID: 22486168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive therapy does not increase operative morbidity in patients with Crohn's disease.
    Bafford AC; Powers S; Ha C; Kruse D; Gorfine SR; Chessin DB; Bauer JJ
    J Clin Gastroenterol; 2013 Jul; 47(6):491-5. PubMed ID: 23090048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of preoperative anti-TNF in surgical and infectious complications of abdominal procedures for Crohn's disease: controversy still persists.
    Kotze PG; Coy CS
    Am J Gastroenterol; 2014 Jan; 109(1):139. PubMed ID: 24402543
    [No Abstract]   [Full Text] [Related]  

  • 16. Crohn's disease recurrence after total proctocolectomy with definitive ileostomy.
    Amiot A; Gornet JM; Baudry C; Munoz-Bongrand N; Auger M; Simon M; Allez M; Cattan P; Sarfati E; Lémann M
    Dig Liver Dis; 2011 Sep; 43(9):698-702. PubMed ID: 21474398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short- and medium-term outcomes following primary ileocaecal resection for Crohn's disease in two specialist centres.
    de Buck van Overstraeten A; Eshuis EJ; Vermeire S; Van Assche G; Ferrante M; D'Haens GR; Ponsioen CY; Belmans A; Buskens CJ; Wolthuis AM; Bemelman WA; D'Hoore A
    Br J Surg; 2017 Nov; 104(12):1713-1722. PubMed ID: 28745410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: an Australian and New Zealand experience.
    Lawrance IC; Radford-Smith GL; Bampton PA; Andrews JM; Tan PK; Croft A; Gearry RB; Florin TH
    J Gastroenterol Hepatol; 2010 Nov; 25(11):1732-8. PubMed ID: 21039834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of risk factors for anastomotic infectious complications following bowel resection for Crohn disease].
    Wang WY; Chen CL; Chen GL; Wu CJ; Li HG; Luan SM; Zhu YB
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Apr; 16(4):328-31. PubMed ID: 23608792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Influence of Preoperative Medications on Postoperative Complications in Patients After Intestinal Surgery for Crohn's Disease.
    Yu CS; Jung SW; Lee JL; Lim SB; Park IJ; Yoon YS; Kim CW; Yang SK; Ye BD; Park SH; Han M; Kim JC
    Inflamm Bowel Dis; 2019 Aug; 25(9):1559-1568. PubMed ID: 30753560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.